MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences, Inc. (GLSI)
source: myfinsight.com
Sale of common stock
via atm program, net...
$9,029,912
Net cash provided by
financing activities
$9,029,912
Net increase
(decrease) in cash
$4,327,414
Canceled cashflow
$4,702,498
Stock-based compensation
$1,544,214
Net cash used in
operating activities
-$4,702,498
Canceled cashflow
$1,544,214
Net loss
-$5,657,137
Accounts payable
-$365,461
Unreimbursed expenses
(accrued)
-$224,114
Back